Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,908 | 57,252 | 60,535 | 100,879 | 105,149 |
| Marketable Securities | 244,600 | 276,387 | 306,165 | 292,981 | 311,774 |
| Receivables | N/A | N/A | 2,000 | 2,000 | 2,000 |
| TOTAL | $320,543 | $343,000 | $375,272 | $401,674 | $436,085 |
| Non-Current Assets | |||||
| PPE Net | 10,881 | 11,106 | 10,884 | 11,296 | 8,359 |
| Other Non-Current Assets | 47,904 | 49,667 | 50,314 | 51,186 | 3,955 |
| TOTAL | $58,785 | $60,773 | $61,198 | $62,482 | $12,314 |
| Total Assets | $379,328 | $403,773 | $436,470 | $464,156 | $448,399 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,793 | 6,296 | 4,453 | 6,314 | 1,693 |
| Accrued Expenses | 13,185 | 10,692 | 17,495 | 15,752 | 14,162 |
| TOTAL | $53,633 | $53,672 | $55,545 | $51,322 | $44,684 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33,848 | 34,011 | 31,792 | 28,475 | 28,200 |
| Other Non-Current Liabilities | 38,082 | 38,735 | 39,361 | 39,947 | 0 |
| TOTAL | $112,750 | $122,837 | $131,449 | $139,762 | $105,011 |
| Total Liabilities | $166,383 | $176,509 | $186,994 | $191,084 | $149,695 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,467 | 88,407 | 88,203 | 88,177 | 88,041 |
| Common Shares | 88 | 88 | 88 | 88 | 88 |
| Retained earnings | -318,230 | -297,520 | -269,512 | -240,452 | -211,402 |
| Other shareholders' equity | -1,517 | -2,201 | -3,705 | -4,856 | -4,347 |
| TOTAL | $212,945 | $227,264 | $249,476 | $273,072 | $298,704 |
| Total Liabilities And Equity | $379,328 | $403,773 | $436,470 | $464,156 | $448,399 |